Qlaira® is associated with high satisfaction rates28

79.5% of women were satisfied or very satisfied with Qlaira®


Satisfaction was measured as a secondary endpoint in a multicenter, open-label efficacy and safety study of Qlaira® over 20 cycles in 1,377 women aged 18–50 years. In the same study, continuation rates were high: 78%. In a separate study of Qlaira® versus ethinyl estradiol (EE)/levonorgestrel (LNG), the overall compliance for Qlaira® was very high: 97.1%.428